Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | 1.11% | 171.58 | 1.3% | $500.69m | |
| BIIB | Biogen Inc. | 1.00% | 235.24 | 1.3% | $484.05m | |
| CELG | Celgene Corporation | 0.13% | 96.37 | 1.3% | $469.21m | |
| GILD | Gilead Sciences, Inc. | -0.02% | 66.51 | 0.9% | $452.08m | |
| ILMN | Illumina, Inc. | 2.24% | 313.33 | 3.5% | $316.73m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 3.38% | 320.42 | 2.6% | $294.11m | |
| A | Agilent Technologies, Inc. | -0.52% | 67.97 | 1.6% | $198.93m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 2.03% | 172.56 | 1.9% | $181.19m | |
| EXAS | Exact Sciences Corporation | -1.88% | 95.13 | 25.3% | $167.62m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.96% | 127.56 | 2.0% | $149.99m | |
| BMRN | BioMarin Pharmaceutical Inc. | 0.41% | 87.83 | 4.3% | $118.19m | |
| SRPT | Sarepta Therapeutics, Inc. | 0.40% | 121.67 | 14.7% | $115.94m | |
| INCY | Incyte Corporation | 0.63% | 79.18 | 2.5% | $107.42m | |
| IONS | Ionis Pharmaceuticals, Inc. | -1.01% | 68.54 | 8.2% | $98.35m | |
| ALNY | Alnylam Pharmaceuticals, Inc | 0.15% | 67.97 | 9.2% | $95.76m |
Company Profile
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.